Abstract
Background: Preconditioning might protect the myocardium against ischemia/ reperfusion injury by reducing infarct size and preventing arrhythmias. Dexmedetomidine (DEX) is a highly selective α2-agonist used for sedoanalgesia in daily anesthetic practice. The cardioprotective effects of DEX on infarct size and on the incidence of arrhythmias observed after regional ischemia/reperfusion injury in vivo have not been reported.
Objective: The aim of this study was to determine whether DEX exhibits a preconditioning effect and reduces infarct size and the incidence and duration of arrhythmias in a regional cardiac ischemia/reperfusion model in rats.
Methods: Adult male Sprague-Dawley rats were anesthetized with sodium thiopental and mechanically ventilated (0.9 mL/100 g at 60 strokes/min) through a cannula inserted into the trachea after tracheotomy. Cardiac ischemia was then produced by ligating the left main coronary artery for 30 minutes, followed by a reperfusion period of 120 minutes. Blood pressure (BP) and heart rate (HR) were monitored and echocardiograms (ECGs) were performed. Arrhythmia was scored based on incidence and duration. The animals were randomly divided into 3 groups. The ischemic preconditioning (IPC) group underwent 5 minutes of ischemia followed by 5 minutes of reperfusion before the 30-minute ischemia/120-minute reperfusion period. In the DEX group, intraperitoneal (IP) DEX 1 mL (100 μg/kg) was administered 30 minutes before the ischemia/ reperfusion period. In the control group, IP saline 1 mL was administered 30 minutes before the ischemia/reperfusion period. After reperfusion, the heart was excised, demarcated with saline and ethanol to identify the occluded and nonoccluded myocardium, and cut into slices ~2 mm thick, that were then stained and placed between 2 glass plates. The risk zone and the infarct zone were compared between groups. The investigator assessing the infarcts was blinded to the study group.
Results: Twenty-one adult (aged 4-6 months) male Sprague-Dawley rats weighing 280 to 360 g were included in the study; 7 rats were assigned to each group. BP, HR, and ECG readings were not significantly different between groups and did not change during the study. Arrythmias occurred during ischemia and reperfusion in all groups. The duration of the arrhythmias was significantly shorter and the arrhythmia score was significantly lower in the IPC group (all, P<0.05), compared with the control group; however, they were not significantly different in the DEX group. During the ischemic period, duration of ventricular tachycardia (VT) and ventricular premature contractions (VPC) in the DEX group was significantly longer than that observed in the IPC group (all, P<0.05). The duration of VPC was also significantly shorter than that observed in the control group (both, P<0.05). Duration of VT during the reperfusion period in the DEX group was significantly longer than that observed in both IPC and control groups (both, P<0.05). The mean (SD) percentage of damage was significantly lower in the IPC group (44.1% [2.0%]) and the DEX group (26.7% [2.0%]) compared with the control group (69.0% [3.0%]; both, P<0.05). The percentage of damage in the DEX group was also significantly lower compared with the IPC group (P<0.05).
Conclusions: This small, experimental in vivo study found that DEX was associated with reduced infarct size in ischemia/reperfusion injury in regional ischemia in this rat model but had no effect on the incidence of arrhythmias. Future studies are needed to clarify these findings.
Key words: dexmedetomidine, preconditioning, cardiac ischemia/reperfusion
Full Text
The Full Text of this article is available as a PDF (862.1 KB).
References
- 1.Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124–1136. doi: 10.1161/01.cir.74.5.1124. [DOI] [PubMed] [Google Scholar]
- 2.Vegh A, Komori S, Szekeres L, Parratt JR. Antiarrhythmic effects of preconditioning in anaesthetised dogs and rats. Cardiovasc Res. 1992;26:487–495. doi: 10.1093/cvr/26.5.487. [DOI] [PubMed] [Google Scholar]
- 3.Vegh A, Papp JG, Parratt JR. Pronounced antiarrhythmic effects of preconditioning in anaesthetized dogs: Is adenosine involved? J Mol Cell Cardiol. 1995;27:349–356. doi: 10.1016/s0022-2828(08)80032-6. [DOI] [PubMed] [Google Scholar]
- 4.Tanaka K, Ludwig LM, Kersten JR. Mechanisms of cardioprotection by volatile anesthetics. Anesthesiology. 2004;100:707–721. doi: 10.1097/00000542-200403000-00035. [DOI] [PubMed] [Google Scholar]
- 5.Bolli R. Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: An overview of a decade of research. J Mol Cell Cardiol. 2001;33:1897–1918. doi: 10.1006/jmcc.2001.1462. [DOI] [PubMed] [Google Scholar]
- 6.Pears JN, Gross ER, Gross GJ. Effect of exogenous kappa-opioid receptor activation in rat model of myocardial infarction. J Crdiovasc Pharmacol. 2004;43:410–415. doi: 10.1097/00005344-200403000-00012. [DOI] [PubMed] [Google Scholar]
- 7.Pears JN, Gross ER, Gross GJ. Opioid-induced preconditioning: Recent advances and future perspectives. Vascul Pharmacol. 2005;42:211–218. doi: 10.1016/j.vph.2005.02.003. [DOI] [PubMed] [Google Scholar]
- 8.Lepran I, Pollesello P, Vajda S. Preconditioning effects of levosimendan in a rabbit cardiac ischemia-reperfusion model. J Crdiovasc Pharmacol. 2006;48:148–152. doi: 10.1097/01.fjc.0000246151.39758.2a. [DOI] [PubMed] [Google Scholar]
- 9.Kamibayashi T, Maze M. Clinical uses of alpha2-adrenergic agonists. Anesthesiology. 2000;93:1345–1349. doi: 10.1097/00000542-200011000-00030. [DOI] [PubMed] [Google Scholar]
- 10.Talke P, Li J, Jain U, Study of Perioperative Ischemia Research Group Effects of perioperative dexmedetomidine infusion in patients undergoing vascular surgery. Anesthesiology. 1995;82:620–633. doi: 10.1097/00000542-199503000-00003. [DOI] [PubMed] [Google Scholar]
- 11.Roekaerts PM, Prinzen FW, De Lange S. Beneficial effects of dexmedetomidine on ischaemic myocardium of anaesthetized dogs. Br J Anaesth. 1996;77:427–429. doi: 10.1093/bja/77.3.427. [DOI] [PubMed] [Google Scholar]
- 12.Okada H, Kurita T, Mochizuki T. The cardioprotective effect of dexmedetomidine on global ischaemia in isolated rat hearts. Resuscitation. 2007;74:538–545. doi: 10.1016/j.resuscitation.2007.01.032. [DOI] [PubMed] [Google Scholar]
- 13.World Medical Association Statement on Animal Use in Biomedical Research [WMA Web site]. WMA; Hong Kong: 1989. http://www.wma.net/e/policylal8.htm Revised in October 2006. Accessed April 4, 2008. [Google Scholar]
- 14.Walker MJ, Curtis MJ, Hearse DJ. The Lambeth Conventions: Guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. Cardiovasc Res. 1988;22:447–455. doi: 10.1093/cvr/22.7.447. [DOI] [PubMed] [Google Scholar]
- 15.Bozdogan O, Ekerbicer N, Suveren E, Bikmaz SP. Effects of adrenaline pretreatment on the arrhythmias observed following ischemia and reperfusion in conscious and anesthetized rats. Exp Clin Cardiol. 2002;7:20–24. [PMC free article] [PubMed] [Google Scholar]
- 16.Lepran I, Koltai M, Siegmund W, Szekeres L. Coronary artery ligation, early arrhythmias, and determination of the ischemic area in conscious rats. J Pharmacol Methods. 1983;9:219–230. doi: 10.1016/0160-5402(83)90041-4. [DOI] [PubMed] [Google Scholar]
- 17.Dahmani S, Rouelle D, Gressens P, Mantz J. Effects of dexmedetomidine on hippocampal focal adhesion kinase tyrosine phosphorylation in physiologic and ischemic conditions. Anesthesiology. 2005;103:969–977. doi: 10.1097/00000542-200511000-00011. [DOI] [PubMed] [Google Scholar]
- 18.Mangano DT, Browner WS, Hollenberg M, Study of Perioperative Ischemia Research Group Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. N Engl J Med. 1990;323:1781–1788. doi: 10.1056/NEJM199012273232601. [DOI] [PubMed] [Google Scholar]
- 19.Willigers HM, Prinzen FW, Roekaerts PM. Dexmedetomidine decreases perioperative myocardial lactate release in dogs. Anesth Analg. 2003;96:657–664. doi: 10.1213/01.ANE.0000048708.75957.FF. [DOI] [PubMed] [Google Scholar]